Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunologic Reconstitution in HIV-1 Infected Children Receiving HAART
NCT00001688Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jan 1998
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of ritonavir, nevirapine and stavudine in human immunodeficiency virus infection (HIV), sponsored by National Cancer Institute. Primary endpoint: Repopulation of naive T cells. Started Jan 1998; status: completed.
02
Drugs
ritonavirnevirapinestavudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00001688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001688.